Riskpilot← Back to searchSign inGet full accessAlpha Omega Medica AB
ABActiveOrg 5591480214Hantverkaregatan 19General medical practice activities · NACE 8621Est. 20180 employees
Revenue 2024
SEK 2M
EBITDA margin
77.3%
Equity ratio
63.3%
Financial strength
Net profit 2024
SEK 954K
0 employees
| Revenue | SEK 2M | — |
| EBITDA | SEK 1,5M | — |
| Net profit | SEK 954K | — |
| Total assets | SEK 3,8M | — |
| Equity | SEK 2,4M | — |
| Employees | 0 | — |
Legal name
Alpha Omega Medica AB
Org number
5591480214
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 februari 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Företaget ska i huvudsak bedriva verksamhet med uthyrning av läkare och psykologer, för arbete inom primärvårdsmottagningar, specialistmottagningar, företagshälsovårdsenheter och vaccinationsmottagningar. Företaget kommer även bedriva verksamhet inom utbildning och handledning av vårdpersonal, estetisk medicin, handel och förvaltning av värdepapper, samt därmed förenlig verksamhet.
Address
Hantverkaregatan 19
Email
panos.papachristou@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 378 | — | 1 241 | — | 1 975 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 165 | 0 | 816 | 0 | 1 526 |
| Depreciation & amort. | −93 | — | −93 | — | −0 |
| EBIT | 72 | 0 | 723 | 0 | 1 526 |
| Net financials | −1 | — | 1 | — | 76 |
| Profit before tax | 71 | 0 | 544 | 0 | 1 201 |
| Tax | −15 | — | −112 | — | −247 |
| Net profit | 56 | — | 432 | — | 954 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 456 | — | 1 289 | — | 3 829 |
| Equity | 244 | — | 775 | — | 2 424 |
| Long-term debt | 100 | — | 0 | — | 0 |
| Short-term debt | 3 | — | 139 | — | 408 |
| Total debt | 103 | — | 139 | — | 408 |
EBITDA margin
77.3%
This company
15.8%
Market median
+389% vs market
20202024
Equity ratio
63.3%
This company
38.2%
Market median
+66% vs market
20202024
Return on equity
39.4%
This company
18.4%
Market median
+114% vs market
20202024
Net profit margin
48.3%
This company
8.1%
Market median
+496% vs market
20202024
Asset turnover
0.52×
This company
1.12×
Market median
-54% vs market
20202024
Debt / equity
0.58×
This company
0.62×
Market median
+6% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PP Chief Executive Officer | Chief Executive Officer | 2022 |
AC Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Alpha Omega Medica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Panagiotis Papachristou | Chief Executive Officer | 0 companies |
| Annelie Christine Lindström | Deputy Chief Executive Officer | 0 companies |